Bioinformatics analysis identifies dysregulation of MiR-۵۴۸F-۳p and its hub gene in triple-negative breast cancer

سال انتشار: 1404
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 99

فایل این مقاله در 10 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_IJBMS-28-4_004

تاریخ نمایه سازی: 8 اسفند 1403

چکیده مقاله:

Objective(s): Triple-negative breast cancer (TNBC), which affects ۱۵–۲۰% of cases, lacks targeted therapies and poses challenges in treatment. MicroRNAs (miRNAs) are potential biomarkers and therapeutic targets in breast cancer. To unravel its unique regulatory role, this study focused on miRNA microarray analysis, particularly miR-۵۴۸F-۳p, in TNBC samples.Materials and Methods: Using the GSE۷۶۲۷۵ dataset, gene expression profiles were analyzed using the Affymetrix Human Genome U۱۳۳ Plus ۲.۰ Array. Differentially expressed genes (DEGs) were identified using robust preprocessing. Weighted gene co-expression network analysis (WGCNA) explored gene modules and identified hub genes co-expressed with miR-۵۴۸F-۳p. Functional enrichment and protein-protein interaction (PPI) network analyses were conducted. Survival analysis was used to assess the prognostic impact of the identified genes.Results: The study found ۲۲۴ up-regulated DEGs, with miR-۵۴۸F-۳p exhibiting significant down-regulation. MultimiR identified ۴۰۰ genes that were targeted by miR-۵۴۸F-۳p. WGCNA revealed a blue co-expression module, with ۳۵۶ genes targeted by miR-۵۴۸F-۳p. A Venn diagram identified common genes, including VANGL۲, BRCC۳, ANP۳۲E, and ANLN. Functional enrichment highlighted crucial pathways in TNBC pathogenesis, including mitotic spindle organization, spindle assembly checkpoint signaling, cell cycle, and amino acid (serine) metabolism. PPI network analysis identified hub genes, including FOXM۱, KIF۲۳, and CDC۲۰. VANGL۲, BRCC۳, ANP۳۲E, and ANLN were significantly associated with patient outcomes in survival analysis.Conclusion: This analysis highlighted TNBC’s molecular landscape, emphasizing miR-۵۴۸F-۳p’s regulatory role. The identified genes, VANGL۲, BRCC۳, ANP۳۲E, and ANLN, offer insights into TNBC pathogenesis and potential therapeutic targets, laying the foundation for understanding their clinical implications in the intricate landscape of TNBC.

کلیدواژه ها:

نویسندگان

Samira Behroozi

National Institute of Genetic Engineering and Biotechnology (NIGEB), Institute of Medical Biotechnology, Department of Medical Genetics, Tehran, Iran

Mahdieh Salimi

National Institute of Genetic Engineering and Biotechnology (NIGEB), Institute of Medical Biotechnology, Department of Medical Genetics, Tehran, Iran

Najaf Allahyari Fard

National Institute of Genetic Engineering and Biotechnology (NIGEB), Tehran, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Liu C, Li Y, Xing X, Zhuang J, Wang J, ...
  • Borri F, Granaglia A. Pathology of triple negative breast cancer. ...
  • Perou CM, Sørlie T, Eisen MB, van de Rijn M, ...
  • Morris GJ, Naidu S, Topham AK, Guiles F, Xu Y, ...
  • Lin NU, Claus E, Sohl J, Razzak AR, Arnaout A, ...
  • Kesireddy M, Elsayed L, Shostrom VK, Agarwal P, Asif S, ...
  • Wu Q, Qian W, Sun X, Jiang S. Small-molecule inhibitors, ...
  • Kumar H, Gupta NV, Jain R, Madhunapantula SV, Babu CS, ...
  • O’Brien J, Hayder H, Zayed Y, Peng C. Overview of ...
  • Olcum M, Tufekci KU, Genc S. MicroRNAs in genetic etiology ...
  • Butte A. The use and analysis of microarray data. Nat ...
  • Langfelder P, Horvath S. WGCNA: An R package for weighted ...
  • Chandrashekar DS, Karthikeyan SK, Korla PK, Patel H, Shovon AR, ...
  • Kleivi Sahlberg K, Bottai G, Naume B, Burwinkel B, Calin ...
  • Gupta I, Sareyeldin RM, Al-Hashimi I, Al-Thawadi HA, Al Farsi ...
  • Song N, Liang B, Wang D. The function of MiR-۲۱ ...
  • Thakur S, Grover RK, Gupta S, Yadav AK, Das BC. ...
  • Pollard J, Burns PA, Hughes TA, Ho-Yen C, Jones JL, ...
  • Seal RL, Braschi B, Gray K, Jones TEM, Tweedie S, ...
  • Su AI, Wiltshire T, Batalov S, Lapp H, Ching KA, ...
  • Konecny GE. Cyclin-dependent kinase pathways as targets for women’s cancer ...
  • Yamamoto T, Kanaya N, Somlo G, Chen S. Synergistic anti-cancer ...
  • Tutt A, Tovey H, Cheang MCU, Kernaghan S, Kilburn L, ...
  • Ibrahim YH, García-García C, Serra V, He L, Torres-Lockhart K, ...
  • Denkert C, Liedtke C, Tutt A, von Minckwitz G. Molecular ...
  • Wenzel ES, Singh ATK. Cell-cycle checkpoints and aneuploidy on the ...
  • Joglekar AP. A cell biological perspective on past, present and ...
  • Carter SL, Eklund AC, Kohane IS, Harris LN, Szallasi Z. ...
  • Dominguez-Brauer C, Thu KL, Mason JM, Blaser H, Bray MR, ...
  • Repo H, Löyttyniemi E, Kurki S, Kallio L, Kuopio T, ...
  • Dashti S, Taheri M, Ghafouri-Fard S. An in-silico method leads ...
  • Ren Y, Deng R, Zhang Q, Li J, Han B, ...
  • Agarwal S, Parija M, Naik S, Kumari P, Mishra SK, ...
  • Williams GH, Stoeber K. The cell cycle and cancer. J ...
  • Chen J, Cui L, Lu S, Xu S. Amino acid ...
  • Jeon H, Kim JH, Lee E, Jang YJ, Son JE, ...
  • Zhang X, Bai W. Repression of phosphoglycerate dehydrogenase sensitizes triple-negative ...
  • Najarro EH, Huang J, Jacobo A, Quiruz LA, Grillet N, ...
  • Hatakeyama J, Wald JH, Printsev I, Ho HY, Carraway KL, ...
  • Puvirajesinghe TM, Bertucci F, Jain A, Scerbo P, Belotti E, ...
  • Dong Y, Hakimi MA, Chen X, Kumaraswamy E, Cooch NS, ...
  • Boudreau HE, Broustas CG, Gokhale PC, Kumar D, Mewani RR, ...
  • Li P, Xu T, Zhou X, Liao L, Pang G, ...
  • Landemaine T, Jackson A, Bellahcène A, Rucci N, Sin S, ...
  • Xiong Z, Ye L, Zhenyu H, Li F, Xiong Y, ...
  • Ruff GL, Murphy KE, Smith ZR, Vertino PM, Murphy PJ. ...
  • Piekny AJ, Maddox AS. The myriad roles of Anillin during ...
  • Zhou W, Wang Z, Shen N, Pi W, Jiang W, ...
  • Magnusson K, Gremel G, Rydén L, Pontén V, Uhlén M, ...
  • Maryam A, Chin YR. ANLN enhances triple-negative breast cancer stemness ...
  • نمایش کامل مراجع